These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26439725)

  • 1. Quantitative analysis of nuclear shape in oral squamous cell carcinoma is useful for predicting the chemotherapeutic response.
    Ogura M; Yamamoto Y; Miyashita H; Kumamoto H; Fukumoto M
    Med Mol Morphol; 2016 Jun; 49(2):76-82. PubMed ID: 26439725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 and Ki-67 as predictive markers for radiosensitivity in squamous cell carcinoma of the oral cavity? an immunohistochemical and clinicopathologic study.
    Koelbl O; Rosenwald A; Haberl M; Müller J; Reuther J; Flentje M
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):147-54. PubMed ID: 11163508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma.
    Perrone F; Bossi P; Cortelazzi B; Locati L; Quattrone P; Pierotti MA; Pilotti S; Licitra L
    J Clin Oncol; 2010 Feb; 28(5):761-6. PubMed ID: 20048189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma.
    Nakazawa M; Ohnishi T; Ohmae M; Chisoku H; Yui S; Iwai S; Sumi T; Fukuda Y; Kishino M; Yura Y
    Int J Clin Pharmacol Res; 2005; 25(3):115-22. PubMed ID: 16366419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma.
    Perisanidis C; Perisanidis B; Wrba F; Brandstetter A; El Gazzar S; Papadogeorgakis N; Seemann R; Ewers R; Kyzas PA; Filipits M
    J Oral Pathol Med; 2012 Jan; 41(1):40-6. PubMed ID: 21883486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor effect of cisplatin in human oral squamous cell carcinoma was enhanced by andrographolide via upregulation of phospho-p53 in vitro and in vivo.
    Chen S; Hu H; Miao S; Zheng J; Xie Z; Zhao H
    Tumour Biol; 2017 May; 39(5):1010428317705330. PubMed ID: 28513299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of cell proliferation kinetics of tumor in neoadjuvant chemotherapy for advanced oral squamous cell carcinoma and its prognostic implications.
    Noguchi M; Kinjyo H; Miyazaki A; Kubota H; Kohama G
    Int J Clin Oncol; 2002 Jun; 7(3):138-44. PubMed ID: 12109514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [p53 mutations and chemoresistance in oromaxillofacial squamous-cell carcinomas. The results of a molecular genetics study of p53 in metastatic oromaxillofacial tumors and an evaluation of the response to neoadjuvant chemotherapeutic treatment].
    Cutilli T; Papola F; Di Emidio P; Leocata P; Corbacelli A
    Minerva Stomatol; 1998; 47(1-2):1-9. PubMed ID: 9578641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Immunological Impact of Chemotherapy on the Tumor Microenvironment of Oral Squamous Cell Carcinoma.
    Takakura H; Domae S; Ono T; Sasaki A
    Acta Med Okayama; 2017 Jun; 71(3):219-226. PubMed ID: 28655941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-operative radio-chemotherapy enhances apoptotic cell death in oral squamous cell carcinoma.
    Doi R; Makino T; Adachi H; Ryoke K; Ito H
    J Oral Pathol Med; 1998 Sep; 27(8):382-7. PubMed ID: 9736427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Basaloid squamous cell carcinoma: clinical pathological and immunohistochemical study].
    Gao Y; Liu X; Pang S
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1998 Sep; 33(5):290-1. PubMed ID: 11774658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
    Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S
    J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydropyrimidine dehydrogenase expression predicts survival outcome and chemosensitivity to 5-fluorouracil in patients with oral squamous cell carcinoma.
    Kobayashi H; Koike T; Nakatsuka A; Kurita H; Sagara J; Taniguchi S; Kurashina K
    Oral Oncol; 2005 Jan; 41(1):38-47. PubMed ID: 15598584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p53 and apoptosis of tumor cells in locally advanced cervical carcinoma after cisplatin based neoadjuvant chemotherapy.
    Garzetti GG; Ciavattini A; Provinciali M; Di Stefano G; Lucarini G; Goteri G; Biagini G
    Anticancer Res; 1996; 16(5B):3229-34. PubMed ID: 8920796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT1 activation in squamous cell cancer of the oral cavity: a potential predictive marker of response to adjuvant chemotherapy.
    Laimer K; Spizzo G; Obrist P; Gastl G; Brunhuber T; Schäfer G; Norer B; Rasse M; Haffner MC; Doppler W
    Cancer; 2007 Jul; 110(2):326-33. PubMed ID: 17559122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance of carbonic anhydrase 9, glucose transporter-1, Ki-67 and p53 expression in oral squamous cell carcinoma.
    Kondo Y; Yoshikawa K; Omura Y; Shinohara A; Kazaoka Y; Sano J; Mizuno Y; Yokoi T; Yamada S
    Oncol Rep; 2011 May; 25(5):1227-33. PubMed ID: 21399882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Ki-67 antigen and p53 protein at invasive tumor front of oral squamous cell carcinoma.
    Verma R; Singh A; Jaiswal R; Chandra A; Verma R; Tak J
    Indian J Pathol Microbiol; 2014; 57(4):553-7. PubMed ID: 25308006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative simultaneous cisplatin- or carboplatin-based chemotherapy and radiotherapy for squamous cell carcinoma of the oral cavity.
    Kirita T; Ohgi K; Tsuyuki M; Kamikaido N; Yamamoto K; Sugimura M
    J Surg Oncol; 1996 Dec; 63(4):240-8. PubMed ID: 8982368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance and toxicity of neoadjuvant docetaxel, cisplatin and 5 fluorouracil regimen in technically unresectable oral cancer in resource limited rural based tertiary cancer center.
    Patil VM; Chakraborty S; Shenoy PK; Manuprasad A; Sajith Babu TP; Shivkumar T; Babu S; Bhatterjee A; Balasubramanian S
    Indian J Cancer; 2014; 51(1):69-72. PubMed ID: 24947100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
    Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
    J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.